In compliance with Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) (Amendments) Regulations, 2018, Sun Pharma Advanced Research Company has informed that it submitted the Related Party Transactions on consolidated basis, in accordance with the applicable accounting standards, for the half year ended 31st March 2021.
The above information is a part of company’s filings submitted to BSE.